SLRX Company Profile and Key Details

Q: Who are the executives of SLRX?

Mr. Mark J. Rosenblum CPAExecutive Vice President of Fin. & Chief Financial OfficerMr. David J. Arthur M.B.A.Chief Executive Officer, Pres & DirectorDr. Nadeem Q. Mirza M.D., M.P.H.Senior Vice President of Clinical Devel.Dr. Daniela Y. SantiestebanDirector of Targeted Protein Degradation Program

NASDAQ : SLRX

Salarius Pharmaceuticals

$0.84

0.19+29.23%

Open: 4:00 PM

Not Actively Trading

64.8

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Salarius Pharmaceuticals, Inc. (SLRX) stock surged +29.23%, trading at $0.84 on NASDAQ, up from the previous close of $0.65. The stock opened at $0.71, fluctuating between $0.69 and $0.90 in the recent session.

Stock Snapshot

0.65

Prev. Close

4.92M

Market Cap

0.6865

Day Low

-0.034653465346534656

P/E Ratio

-24.24

EPS (TTM)

-3.26

Cash Flow per Share

0.71

Open

5.86M

Number of Shares

0.8976

Day High

99.86%

Free Float in %

1.34

Book Value

5.96M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 07, 2026	0.71	0.90	0.69	0.84	5.97M
Jan 06, 2026	0.52	0.66	0.52	0.65	699.67K
Jan 05, 2026	0.55	0.57	0.51	0.54	1.32M
Jan 02, 2026	0.65	0.67	0.64	0.65	370.41K
Dec 31, 2025	0.66	0.68	0.64	0.65	67.41K
Dec 30, 2025	0.64	0.66	0.63	0.65	187.73K
Dec 29, 2025	0.66	0.66	0.62	0.64	195.74K
Dec 26, 2025	0.63	0.66	0.63	0.66	98.24K
Dec 24, 2025	0.64	0.67	0.62	0.64	111.49K
Dec 23, 2025	0.65	0.67	0.65	0.65	294.77K
Dec 22, 2025	0.71	0.71	0.65	0.67	261.43K
Dec 19, 2025	0.67	0.72	0.66	0.69	222.68K
Dec 17, 2025	0.72	0.73	0.65	0.65	382.61K
Dec 16, 2025	0.78	0.84	0.72	0.72	286.46K
Dec 15, 2025	0.78	0.90	0.77	0.78	657.72K
Dec 12, 2025	0.80	0.81	0.78	0.78	128.59K
Dec 11, 2025	0.84	0.84	0.78	0.81	397.37K
Dec 10, 2025	0.82	0.89	0.80	0.87	286.34K
Dec 09, 2025	0.85	0.85	0.82	0.83	177.19K
Dec 08, 2025	0.87	0.87	0.81	0.83	400.77K

Contact Details

Houston, TX 77021

United States

https://www.salariuspharma.com 832 834 6992

About Company

Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to advancing epigenetic-based cancer therapies. Its flagship investigational product, Seclidemstat (SP-2577), a small molecule inhibitor, is currently undergoing Phase I/II clinical evaluation. This compound is being developed to treat Ewing sarcoma and a range of advanced solid tumors. Another promising program involves SP-3164, a small molecule protein degrader designed to target both hematological and solid malignancies. The company has cultivated several key alliances. These include an exclusive licensing agreement with The University of Utah Research Foundation for the intellectual property associated with SP-2577 and related compounds. A collaboration with HLB Life Sciences grants rights for the comprehensive development, production, and commercialization of the drug in South Korea. Furthermore, Salarius partners with the Cancer Prevention and Research Institute of Texas (CPRIT) to accelerate product development activities. A research collaboration with the Cancer Epigenetics Institute at Fox Chase Cancer Center aims to uncover new indications and biomarkers for SP-2577. Corporate operations are managed from its headquarters in Houston, Texas.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current Salarius Pharmaceuticals, Inc. (SLRX) stock price?

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) stock price is $0.84 in the last trading session. During the trading session, SLRX stock reached the peak price of $0.90 while $0.69 was the lowest point it dropped to. The percentage change in SLRX stock occurred in the recent session was 29.23% while the dollar amount for the price change in SLRX stock was $0.19.

SLRX's industry and sector of operation?

The NASDAQ listed SLRX is part of Biotechnology industry that operates in the broader Healthcare sector. Salarius Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SLRX?

Mr. Mark J. Rosenblum CPA
Executive Vice President of Fin. & Chief Financial Officer
Mr. David J. Arthur M.B.A.
Chief Executive Officer, Pres & Director
Dr. Nadeem Q. Mirza M.D., M.P.H.
Senior Vice President of Clinical Devel.
Dr. Daniela Y. Santiesteban
Director of Targeted Protein Degradation Program

How SLRX did perform over past 52-week?

SLRX's closing price is 63.11% higher than its 52-week low of $0.52 where as its distance from 52-week high of $52.95 is -98.41%.

How many employees does SLRX have?

Number of SLRX employees currently stands at 2.

Link for SLRX official website?

Official Website of SLRX is: https://www.salariuspharma.com

How do I contact SLRX?

SLRX could be contacted at phone 832 834 6992 and can also be accessed through its website. SLRX operates from 2450 Holcombe Boulevard, Houston, TX 77021, United States.

How many shares of SLRX are traded daily?

SLRX stock volume for the day was 5.96M shares. The average number of SLRX shares traded daily for last 3 months was 3.68M.

What is the market cap of SLRX currently?

The market value of SLRX currently stands at $4.92M with its latest stock price at $0.84 and 5.86M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2
Beta	0.32
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	2
Beta	0.32
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SLRX Company Profile and Key Details

Salarius Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics